Windlas Biotech Board of Directors

Get the latest insights into the leadership at Windlas Biotech. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Vivek Dhariwal Chairman & Ind.Director
Mr. Hitesh Windlass Managing Director
Mr. Manoj Kumar Windlass Joint Managing Director
Mr. Pawan Kumar Sharma Executive Director
Mr. Ashok Kumar Windlass Whole Time Director
Mrs. Prachi Jain Windlass Non Executive Director
Mr. Srinivasan Venkataraman Independent Director
Mr. Gaurav Gulati Independent Director

Windlas Biotech Share price

WINDLAS

988

8.20 (0.84%)
NSE
BSE
Last updated on 4 Sep, 2025 | 15:29 IST
BUYSELL
Today's High

995.95

Today's Low

969.90

52 Week Low

665.10

52 Week High

1198.25

The current prices are delayed, login to your account for live prices

Windlas Biotech FAQs

The board at Windlas Biotech consists of experienced professionals, including Mr. Vivek Dhariwal , Mr. Hitesh Windlass , and others, overseeing the company’s strategic and corporate governance.

Directors at Windlas Biotech are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Vivek Dhariwal is the current chairman at Windlas Biotech.

Executive directors at Windlas Biotech are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Windlas Biotech adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Windlas Biotech, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.